1 |
Funke S, Risch A, Nieters A, et al (2009b). Genetic polymorphisms in genes related to oxidative stress (GSTP1, GSTM1, GSTT1, CAT, MnSOD, MPO, eNOS) and survival of rectal cancer patients after radiotherapy. J Cancer Epidemiol, 2009, 302047.
|
2 |
Hildebrandt MA, Komaki R, Liao Z, et al (2010). Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One, 5, 12402.
DOI
|
3 |
Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, et al (2011). A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer. Pharmacogenomics J, 11, 437-43.
DOI
|
4 |
Jang MJ, Jeon YJ, Kim JW, et al (2013). Association of eNOS polymorphisms (-786T>C, 4a4b, 894G>T) with colorectal cancer susceptibility in the Korean population. Gene, 512, 275-81.
DOI
ScienceOn
|
5 |
Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
DOI
|
6 |
Kassab A, Msolly A, Lakhdar R, Gharbi O, Miled A (2014). Polymorphisms of glutathione-S-transferases M1, T1, P1 and susceptibility to colorectal cancer in a sample of the Tunisian population. Med Oncol, 31, 760.
DOI
|
7 |
Kelly RA, Balligand JL, Smith TW (1996). Nitric oxide and cardiac function. Circulation Research, 79, 363-80.
DOI
ScienceOn
|
8 |
Kim YJ, Lee SJ, Kim JG, et al (2011). No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer. Med Oncol, 28, 1075-9.
DOI
|
9 |
Chaleshi V, Haghighi MM, Savabkar S, et al (2013). Correlation between the EGF gene intronic polymorphism, rs2298979, and colorectal cancer. Oncol Lett, 6, 1079-83.
|
10 |
Brankovic A, Brajuskovic G, Nikolic Z, et al (2013). Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population. Int J Exp Pathol, 94, 355-61.
DOI
ScienceOn
|
11 |
Center MM, Jemal A, Smith RA, Ward E (2009). Worldwide variations in colorectal cancer. CA Cancer J Clin, 59, 366-78.
DOI
ScienceOn
|
12 |
Conde MC, Ramirez-Lorca R, Lopez-Jamar JM, et al (2006). Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol Rep, 16, 353-9.
|
13 |
Cunningham D, Atkin W, Lenz HJ, et al (2010). Colorectal cancer. Lancet, 375, 1030-47.
DOI
ScienceOn
|
14 |
Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
15 |
Fatini C, Sofi F, Sticchi E, et al (2004). Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J, 147, 516-21.
DOI
|
16 |
Fraga LR, Paludo FJ, Bos AJ, et al (2013). More severe clinical course of cardiovascular dysfunction in intensive care unit patients with the 894TT eNOS genotype. Genet Mol Res, 12, 562-8.
DOI
|
17 |
Arikan S, Cacina C, Guler E, et al (2012). The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. Mol Biol Rep, 39, 3245-9.
DOI
ScienceOn
|
18 |
Funke S, Hoffmeister M, Brenner H, Chang-Claude J (2009a). Effect modification by smoking on the association between genetic polymorphisms in oxidative stress genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 18, 2336-8.
DOI
ScienceOn
|
19 |
Aguilar-Melero P, Ferrin G, Muntane J (2012). Effects of nitric oxide synthase-3 overexpression on post-translational modifications and cell survival in HepG2 cells. J Proteomics, 75, 740-55.
DOI
|
20 |
Ames BN (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science, 221, 1256-64
DOI
ScienceOn
|
21 |
Moochhala S, Chhatwal VJ, Chan ST, et al (1996). Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis, 17, 1171-4.
DOI
ScienceOn
|
22 |
Yagihashi N, Kasajima H, Sugai S, et al (2000). Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch, 436, 109-14.
DOI
ScienceOn
|
23 |
Yeh CC, Santella RM, Hsieh LL, Sung FC, Tang R (2009). An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int J Cancer, 124, 1565-71.
DOI
ScienceOn
|
24 |
Zhao P, Dai M, Chen W, Li N (2010). Cancer trends in China. Jpn J Clin Oncol, 40, 281-5.
DOI
ScienceOn
|
25 |
Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6.
DOI
ScienceOn
|
26 |
Razavi HM, Hamilton JA, Feng Q (2005). Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol Ther, 106, 147-62.
DOI
|
27 |
Luo L, Li DH, Wei SG, et al (2013). Polymorphisms in the endothelial nitric oxide synthase gene associated with recurrent miscarriage. Genet Mol Res, 12, 3879-86.
DOI
|
28 |
Oh NJ, Ryu KY, Jung CN, Yi SY, Kim SR (2013). Expression of endothelial nitric oxide synthase in the uterus of patients with leiomyoma or adenomyosis. J Obstet Gynaecol Res, 39, 536-42.
DOI
|
29 |
Pfeifer GP, Denissenko MF, Olivier M, et al (2002). Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene, 21, 7435-51
DOI
ScienceOn
|
30 |
Ryk C, Wiklund NP, Nyberg T, de Verdier PJ (2011). Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer. Nitric Oxide, 25, 338-43.
DOI
ScienceOn
|
31 |
Terrazzino S, La Mattina P, Masini L, et al (2012). Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiother Oncol, 103, 199-205.
DOI
ScienceOn
|
32 |
Yao L, Fang F, Zhong Y, Yu L (2010). The association between two polymorphisms of eNOS and breast cancer risk: a metaanalysis. Breast Cancer Res Treat, 124, 223-7.
DOI
|
33 |
Ikeda S, Sasazuki S, Natsukawa S, et al (2008). Screening of 214 single nucleotide polymorphisms in 44 candidate cancer susceptibility genes: a case-control study on gastric and colorectal cancers in the Japanese population. Am J Gastroenterol, 103, 1476-87.
DOI
|
34 |
Dan S, Bai L, Li-Jie W, Ting Z, Zhi-Yuan M (2013). Pharmacogenetic angiogenesis profiling for first-line chemotherapy in patients with advanced gastric cancer. Cancer Invest, 31, 390-6.
DOI
|
35 |
Verim L, Toptas B, Ozkan NE, et al (2013). Possible relation between the NOS3 gene GLU298ASP polymorphism and bladder cancer in Turkey. Asian Pac J Cancer Prev, 14, 665-8.
과학기술학회마을
DOI
ScienceOn
|